| Bioactivity | DCN1-UBC12-IN-3 is potent and selective DCN1-UBC12 inhibitor with an IC50 of 2.25 nM. Anticardiac fibrotic effect[1]. |
| Invitro | DCN1-UBC12-IN-3 (compound 49) possesses low cytotoxicity toward cardiac fibroblasts (CFs) with an IC50 of 2578 μM for 24 h[1]. |
| Name | DCN1-UBC12-IN-3 |
| CAS | 2374827-45-7 |
| Formula | C30H30N8O3S2 |
| Molar Mass | 614.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. He ZX, et al. Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects. J Med Chem. 2022;65(1):163-190. |
DCN1-UBC12-IN-3
CAS: 2374827-45-7 F: C30H30N8O3S2 W: 614.74
DCN1-UBC12-IN-3 is potent and selective DCN1-UBC12 inhibitor with an IC50 of 2.25 nM. Anticardiac fibrotic effect.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.